Literature DB >> 171512

Steroid hormone receptors in human breast cancer and the clinical significance.

H Maass, B Engel, G Trams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 171512     DOI: 10.1016/0022-4731(75)90062-x

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


× No keyword cloud information.
  7 in total

1.  Hormone receptors in breast cancer.

Authors: 
Journal:  Br Med J       Date:  1978-07-08

2.  Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor.

Authors:  R Hackenberg; T Hawighorst; A Filmer; A H Nia; K D Schulz
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

3.  Growth inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by controlled-release low-dose medroxyprogesterone acetate.

Authors:  S Li; M Lepage; Y Mérand; A Bélanger; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

4.  [Development of new antiestrogens of the 3,3'-dihydroxy-alpha, beta-diethylstilbene-type and their evaluation on the DMBA-induced hormone dependent mammary carcinoma of the SD-rat (author's transl)].

Authors:  G Kranzfelder; M Schneider; E von Angerer; H Schönenberger
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

5.  Prognostic significance of the steroid receptor content in primary breast cancer.

Authors:  K von Maillot; W Horke; H Prestele
Journal:  Arch Gynecol       Date:  1982

6.  Correlations of the receptor content and ultrastructure of breast cancer cells.

Authors:  A H Tulusan; M Hamann; H Prestele; I Ramming; K von Maillot; H Egger
Journal:  Arch Gynecol       Date:  1982

7.  Soluble and nuclear oestrogen receptor status of advanced endometrial cancer in relation to subsequent clinical prognosis.

Authors:  L Castagnetta; M Lo Casto; O M Granata; M Calabro; M Ciaccio; R E Leake
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.